Philips Enables Digitization of Tumor Tissue Research at Institut Curie to Combat Cancer

Royal Philips Electronics

Philips is collaborating with Institut Curie who is now able to digitize tumor analysis research, with the aim of speeding up and improving cancer diagnosis and treatment. Today pathologists view tissue sample images manually using a microscope. By using Philips Digital Pathology Solution, Institut Curie hopes to increase workflow efficiency and consolidate its pathology activities at multiple sites into one single virtual laboratory.

As well as the diagnosis of tissue from patients with cancer indications, the pathology department at Institut Curie evaluates thousands of test samples from experimental cancer research programs worldwide to gain a better understanding of the causes and mechanisms of diseases at both cellular and molecular level. These new insights may give rise to new diagnostic approaches and therapeutic treatments.

Currently, Institut Curie produces and diagnoses more than 200,000 glass pathology slides every year using a microscope. Digitalization of the pathology workflow could ease this logistical burden and enable new ways of working, such as real-time collaboration with peers and creation of a virtual network across the globe. Moreover, in cancer research, digital histopathology information can now, for example, be added to biology data and this opens up new ways to mine information from tumor tissue for further data analysis.

"Digitalization of pathology will enable us to keep momentum going to accelerate cancer research and, in the end, improve patient care," says Xavier Sastre-Garau, director of the Biopathology Department of Institut Curie.

"Philips' digital pathology solution is empowering Institut Curie to realize a single virtual laboratory that offers new opportunities for intensive collaboration," says Guido du Pree, vice president of Marketing & Sales for Philips Digital Pathology Solutions.

To support its cancer research, Insitut Curie has completed installation of the fully integrated Philips Digital Pathology Solution with ultrafast scanners at its locations in Paris and St. Cloud, which are connected on-line through an image management system that provides an interface to communicate with commercially available Laboratory Information Systems (LIS). Institut Curie benefited for this acquisition from the support of the National Cancer Institute, SiRIC grant with reference "INCa-DGOS-4654".

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...